PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Promising results for Swedish cancer drug candidate

2013-12-06
(Press-News.org) Contact information: The Press Office
pressinfo@ki.se
46-852-486-077
Karolinska Institutet
Promising results for Swedish cancer drug candidate A new study conducted by scientists from the Dana-Farber Cancer Institute at Harvard Medical School and Karolinska Institutet in Sweden presents very promising results for the treatment of the cancer form multiple myeloma. The drug candidate used in the research has been developed by scientists from Karolinska Institutet and a Swedish company following its initial identification at the same university. The findings are so promising that the scientists are teaming up with Harvard to bring the drug to clinical trials on patients.

The journal Blood has published a new study on a drug candidate for multiple myeloma, a form of cancer that affects about one per cent of all tumour patients, with some 600 people a year developing the disease in Sweden. Multiple myeloma is a life-threatening disease and there is a dire medical need for new therapies, especially for the patients whose tumour cells have become resistant to the conventional drugs.

"The discovery that our substance works on multiple myeloma cells resistant to conventional therapy is very promising for the future," says Professor Stig Linder at Karolinska Institutet's Department of Oncology-Pathology. "We're now very hopeful that we and our colleagues at Harvard Medical School will be able to develop an effective treatment."

The study demonstrates that the drug candidate, called VLX1570, inhibits tumour growth and prolongs survival in preclinical multiple myeloma models. The exact mechanism of action of the substance was identified earlier at Karolinska Institutet (Nature Medicine, 2011); put simply, the tumour cells can be said to be more sensitive than normal cells to disruption to the machinery that breaks down defective proteins. When this machinery is blocked, it triggers apoptosis (programmed cell death) in the tumour cells.

"We show that the drug candidate kills multiple myeloma cells from cancer patients," says Professor Linder. "The substance is also effective against myeloma cells that have developed a resistance to the clinically used drug bortezomib."

Dr Dharminder Chauhan at Harvard Medical School says that the mechanism of action is very interesting as regards the development of new cancer drugs and adds, "We're delighted to be able to study the therapeutic potential of this new drug candidate in clinical studies. We hope that the joint research we're doing will lead to improved cancer treatments."

The study also found that the new substance could be combined synergistically with other cancer therapies. Karolinska Institutet and Harvard Medical School are due to launch a large-scale clinical study next year in association with drug discovery company Vivolux AB (Uppsala, Sweden).

"If the study proves successful it will represent a great step forward, mainly for all cancer patients but also for the Swedish drug industry," says Professor Linder.

### The research was funded by the NIH, the American Cancer Society, the Swedish Cancer Society, the Swedish Research Council, Alex and Eva Wallström Foundation, Åke Olsson Foundation, the Cancer Research Foundations of Radiumhemmet, the Swedish Foundation for Strategic Research, and Vivolux AB.

Publication: 'A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in myeloma cells and overcomes Bortezomib resistence', Tian Z, D'Arcy P, Wang X, Ray A, Tai Y-T, Hu Y, Carrasco R, Linder S, Chauhan D, Anderson K, Blood, online 6 December 2013.

Contact the Press Office and download images: ki.se/pressroom

Journal website: bloodjournal.hematologylibrary.org

Karolinska Institutet - a medical university: ki.se/english


ELSE PRESS RELEASES FROM THIS DATE:

Surprising discovery: The skin communicates with the liver

2013-12-06
Surprising discovery: The skin communicates with the liver Researchers from the University of Southern Denmark have discovered that the skin is capable of communicating with the liver. The discovery has surprised the scientists, and they say that it may help our understanding ...

Human stem cells predict efficacy of Alzheimer drugs

2013-12-06
Human stem cells predict efficacy of Alzheimer drugs Researchers from the University of Bonn use reprogrammed patient neurons for drug testing Why do certain Alzheimer medications work in animal models but not in clinical trials in humans? A research team ...

New study finds corn oil superior to extra virgin olive oil in lowering cholesterol

2013-12-06
New study finds corn oil superior to extra virgin olive oil in lowering cholesterol Plant sterols naturally found in corn oil linked to heart health benefits WASHINGTON, December 6, 2013 – Corn oil significantly reduces cholesterol with more favorable changes ...

Enzalutamide in prostate cancer: Hints of added benefit

2013-12-06
Enzalutamide in prostate cancer: Hints of added benefit Longer overall survival in patients without visceral metastases / bone complications and pain progression delayed Enzalutamide (trade name: Xtandi) has been approved since ...

Study finds parental stress linked to obesity in children

2013-12-06
Study finds parental stress linked to obesity in children Effects on Hispanic children more pronounced TORONTO, Dec. 6, 2013—Parental stress is linked to weight gain in children, according to a new study from St. Michael's Hospital. The study found that children ...

What is the link between erectile dysfunction and heart disease?

2013-12-06
What is the link between erectile dysfunction and heart disease? New Rochelle, NY, December 6, 2013—Erectile dysfunction (ED) is caused by the inability of the artery that supplies blood to the penis to expand and contract properly. The ...

Coal yields plenty of graphene quantum dots

2013-12-06
Coal yields plenty of graphene quantum dots Rice U. scientists find simple method for producing dots in bulk from coal, coke HOUSTON – (Dec. 6, 2013) – The prospect of turning coal into fluorescent particles may sound too good to be true, but the possibility exists, thanks ...

Graphene: Growing giants

2013-12-06
Graphene: Growing giants Huge grains of copper promote better graphene growth WASHINGTON D.C. Dec. 6, 2013 -- To technology insiders, graphene is a certified big deal. The one-atom thick carbon-based material elicits rhapsodic descriptions as the strongest, ...

1 percent of the population is responsible for 63 percent of violent crime convictions

2013-12-06
1 percent of the population is responsible for 63 percent of violent crime convictions The majority of all violent crime in Sweden is committed by a small number of people. They are almost all male (92%) who early in life develops violent criminality, substance abuse ...

Frequent cell phone use linked to anxiety, lower grades and reduced happiness in students

2013-12-06
Frequent cell phone use linked to anxiety, lower grades and reduced happiness in students Today, smartphones are central to college students' lives, keeping them constantly connected with friends, family and the Internet. Students' cell phones are rarely out of reach ...

LAST 30 PRESS RELEASES:

Different types of depression linked to different cardiometabolic diseases

Ketogenic diet may protect against stress experienced in the womb

Adults 65 years and older not immune to the opioid epidemic, new study finds

Artificial intelligence emerging as powerful patient safety tool in pediatric anesthesia

Mother’s ZIP code, lack of access to prenatal care can negatively impact baby’s health at birth, new studies show

American Society of Anesthesiologists honors John M. Zerwas, M.D., FASA, with Distinguished Service Award

A centimeter-scale quadruped piezoelectric robot with high integration and strong robustness

Study confirms that people with ADHD can be more creative. The reason may be that they let their mind wander

Research gives insight into effect of neurodegenerative diseases on speech rhythm

Biochar and plants join forces to clean up polluted soils and boost ecosystem recovery

Salk scientist Joseph Ecker awarded McClintock Prize for Plant Genetics and Genome Studies

ADHD: Women are diagnosed five years later than men, despite symptoms appearing at the same age.

Power plants may emit more pollution during government shutdowns

Increasing pressures for conformity de-skilling and demotivating teachers, study warns

Researchers develop smarter menstrual product with potential for wearable health monitoring

Microwaves for energy-efficient chemical reactions

MXene current collectors could reduce size, improve recyclability of Li-ion batteries

Living near toxic sites linked to aggressive breast cancer

New discovery could open door to male birth control

Wirth elected Fellow of American Physical Society

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: October 10, 2025

Destined to melt

Attitudes, not income, drive energy savings at home

The playbook for perfect polaritons

‘Disease in a dish’ study of progressive MS finds critical role for unusual type of brain cell

Solar-powered method lights the way to a ‘de-fossilized’ chemical industry

Screen time linked to lower academic achievement among Ontario elementary students

One-year outcomes after traumatic brain injury and early extracranial surgery in the TRACK-TBI Study

Enduring outcomes of COVID-19 work absences on the US labor market

Affirmative action repeal and racial and ethnic diversity in us medical school admissions

[Press-News.org] Promising results for Swedish cancer drug candidate